CCL2 and Hyperglycemia: Verma et al. (35) in vitro study confirmed that pro-atherogenic effects of hs-CRP were potentiated in the presence of hyperglycemia with increasing of ET-1 production and up regulated adhesion molecules and monocyte chemoattractant chemokine (MCP-1) expression in venous endothelial.